Femasys Inc. has announced the pricing of an $8.0 million underwritten public offering, with the company planning to use the funds for the expansion of commercial efforts, product development, and other corporate purposes. The offering consists of 10,434,586 shares of common stock and pre-funded warrants for up to 11,750,000 shares, accompanied by common warrants for an aggregate of 22,184,586 shares. The shares and accompanying warrants are priced at $0.36 each, with certain company officers offered at a price of $0.5151. The accompanying common warrants, exercisable immediately, will expire five years from issuance. The offering is expected to close around August 27, 2025, pending customary conditions, with Jones and Laidlaw & Company $(UK)$ Ltd. serving as joint book-running managers.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.